Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD)

Saved in:

Bibliographic Details
Main Authors:	Raymond A. Ng, Susanna Barratt, Alison Parisian, Gopinath S. Palanisamy, Samiron Phukan, Richard Sun, Brandon Robello, Guadalupe Peña, Judevin Sapugay, David Yeghikyan, Chenbo Wang, Samir Satish Kher, Srinivasan Thangathirupathy, Robert Millikin, Guijun Yu, Teruki Watanabe, Fei Zhou, Brian Rich, Alexis Duncan, Samuel E. Andersen, Reena Chawla, David R. Zak, Dirk A. Heerding, Brian R. Hearn, Geoffrey Greene, Cyrus L. Harmon, Leslie Hodges-Gallagher, Peter J. Kushner, Sean W. Fanning, David C. Myles
Format:	Article
Language:	English
Published:	American Chemical Society 2025-05-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.4c11023
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet